Matthew A. Brodsky, M.D.
- Email:
- click here
- Office:
- 503 494-7772
Background
Dr. Brodsky joined the OHSU movement disorders faculty in 2002, and is currently an Associate Professor of Neurology. He completed his medical degree, neurology residency and movement disorders fellowship at the Mount Sinai Medical Center in New York City. Dr. Brodsky’s research interests focus on pre-clinical detection and neuroprotective interventions for Parkinson’s disease. He also directs annual courses on deep brain stimulation and the annual meeting of the Pacific Northwest Basal Ganglia Coterie, of which he is a co-founder. Dr. Brodsky oversees clinical trials in dystonia as well as fellowship training in botulinum toxin injection and DBS programming at OHSU. Dr. Brodsky has lectured on Parkinson’s disease around the world, and has authored numerous peer-reviewed publications in the field of movement disorders. In his spare time, he enjoys spending time with his family and friends hiking and skiing the great outdoors of the Pacific Northwest, or playing music for them on his guitar.
Selected Publications
"A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease,"
"Deep brain stimulation versus best medical therapy for PD,"
"Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia,"
"Effects of a dopamine agonist on the pharmacodynamics of levodopa in parkinson disease,"
"The patients' perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD,"
